Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2006
11/22/2006EP1539184B1 Estrogen replacement regimen
11/22/2006EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006EP1360186B1 Carboline derivatives
11/22/2006EP1244401B1 Drug delivery of phase changing formulation
11/22/2006EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006EP0970104B1 Steroid sulfamates, method for the production and use thereof
11/22/2006CN1867353A Use of LH for generating libido and reaching orgasm in female subjects
11/22/2006CN1867349A Composition and method of treatment for urogenital conditions
11/22/2006CN1865276A Method for synthesizing steroid progestogen
11/22/2006CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006CN1864743A Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
11/22/2006CN1864724A Liquid capsule for treating mammary glands hyperplasia and breast distending pain and preparation method thereof
11/22/2006CN1864707A Vaginal effervescence tablet of Ainsliaea fragrans and preparation method thereof
11/22/2006CN1864689A Subcutaneous implant of mifespristone and use thereof in treatment of endometriosis
11/22/2006CN1864664A Lmiquimod cream and preparation method thereof
11/22/2006CN1285594C Oxytocin agonists
11/22/2006CN1285375C Chinese medicine preparation for treating climacteric syndrome of liver depression and qi stagnation and method for preparing same
11/22/2006CN1285372C Preparation method of Chinese medicine oral preparation for treating gynecologic inflammation
11/22/2006CN1285369C Chinese medicine for treating gynopathy
11/22/2006CN1285348C Breast enlarging composition, its preparing method and use
11/22/2006CN1285344C Method for preparing acanthopanax injectio
11/21/2006US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006US7138426 Estrogen receptor modulators
11/21/2006US7138417 Inhibitors of integrin αvβ6
11/21/2006US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006CA2248604C An aphrodisiac for application to the sexual organs
11/21/2006CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/18/2006CA2547251A1 Fused pyrazolyl compounds for cancer treatment
11/16/2006WO2006121104A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006WO2006120412A1 Pharmaceutical formulation of apomorphine for buccal administration
11/16/2006WO2005115389A3 Specific ppar agonists for treating negative energy balance
11/16/2006WO2005115369A3 Use of ppar agonists to treat ruminants
11/16/2006WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006US20060258568 Use of human chorionic gonadotropin in the treatment in the treatment of symptoms endometriosis
11/16/2006US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006US20060257459 Carrier
11/16/2006US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006US20060257330 Powdery pharmaceutical compositions for inhalation
11/16/2006US20060257329 Delivery of drug esters through an inhalation route
11/16/2006DE102005023301A1 Medicament used to reduce risk of e.g. heart disease and urinary tract disease, comprises 5-methyl-(6S)-tetrahydrofolate, estrogen and/or gestagene, vitamin B6 and/or vitamin B2 and auxiliary or carrier materials
11/16/2006DE102005021364A1 Use of a cationic polymer with an organic quaternary ammonium salt as a biocidal active agent, is obtained by the radical polymerization of an ethylenic unsaturated polymerizable compound (monomer)
11/16/2006DE102005021363A1 Biozide Beschichtungen Biocidal coatings
11/16/2006CA2607802A1 Pharmaceutical formulation of apomorphine for buccal administration
11/16/2006CA2607639A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/15/2006EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006EP1721608A2 Upregulation of type III endothelial cell nitric oxide synthase by HMG-CoA reductase inhibitors
11/15/2006EP1547612A4 Medicinal agent and method for curing erectile dysfunction
11/15/2006EP1474127B1 Biphenyl derivatives and their use as antiandrogenic agents
11/15/2006EP1427733B1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
11/15/2006EP1411881B9 5ht2c receptor modulators
11/15/2006EP1399143B1 Use of acetyl l-carnitine for the preparation of a medication to treat anhedonia
11/15/2006EP1007514B1 Heterocyclic ketones as npy y5 antagonists
11/15/2006CN1864434A Wireless microphone communication system
11/15/2006CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006CN1863537A Extended triphasic contraceptive regimens
11/15/2006CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006CN1861186A Medicinal composition for treating chronic pelvic inflammatory disease, prepn. method and quality control method therefor
11/15/2006CN1861183A Traditional Chinese medicine capsule for treating mammary gland diseases
11/15/2006CN1861180A Method for preparing extractive of traditional Chinese medicine sarsa and its quality control method
11/15/2006CN1861175A Medicinal decoction for treating damp-heat bottom-pour type male hemospermia disease and its prepn. method
11/15/2006CN1861174A Medicinal decoction for treating damp-heat aperture-blocking type male sterility, and its prepn. method
11/15/2006CN1861167A Medicinal decoction for blood-insufficiency type male sterility and its prepn. method
11/15/2006CN1861166A Medicinal composition for treating hyperinsulinar type polycystic overies and its prepn. method
11/15/2006CN1861164A Medicinal decoction for treating yin-deficiency and strong internal-heat type male sterility and its prepn. method
11/15/2006CN1861162A Medicinal decoction for treating kidney essence deficiency type male sterility and its prepn. method
11/15/2006CN1861161A Medicinal decoction for treating spleen and kidney yang insufficiency type male hemospermia disease and its prepn. method
11/15/2006CN1861160A Medicinal decoction for treating liver-depression and spleen-insufficiency type male sterility and its prepn. method
11/15/2006CN1861159A Medicinal decoction for treating kidney-yang deficiency type male-sterility and its prepn. method
11/15/2006CN1861149A Medicinal decoction for treating blood-stasis aperture-blocking type male blood-semen disease and its prepn. method
11/15/2006CN1861145A Medicinal decoction for treating kidney-yin deficiency type male sterility and its prepn. method
11/15/2006CN1861123A Formula and prepn. method for gemma agrimoninae vagina effervescence tablets
11/15/2006CN1861100A External use oil agent for treating proliferation of mammary gland and its prepn. method
11/15/2006CN1861082A Medicine prepn. of compounding deoxypregnene contg. non-ionic surfactant
11/15/2006CN1861081A Use of phytolaccatoxin for preparing medicine to treat mazoplasia
11/15/2006CN1861080A Use of phytolaccagenin in preparing medicine for treating azoplasia
11/15/2006CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006CN1284592C Chinese traditional medicine preparation for nourishing face and preparation method
11/15/2006CN1284586C Medicine capsule for treating male infertility
11/15/2006CN1284565C Plaster of Chinese traditional medicine for treating prospermia and preparation method
11/15/2006CN1284549C Oral taking preparation of Chinese traditional medicine for promoting lactation
11/15/2006CN1284546C Thesium Chinese total flavone preparation method
11/14/2006US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006US7135490 Method for the treatment of glomerulonephritis
11/14/2006US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006US7135474 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
11/14/2006US7135453 Reagents and methods for smooth muscle therapies
11/14/2006US7135195 Colorless antimicrobioal aqueous suspension of colloidal silver particles having an interior of elemental silver and a surface of silver oxide of given particle diameters; antiseptic and surface disinfectant and for treatment of viral, fungal, and bacterial infections
11/14/2006CA2214072C Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
11/14/2006CA2128955C Tricyclic benzazepine vasopressin antagonists
11/09/2006WO2006118328A1 Degranulation inhibitor
11/09/2006WO2006118320A1 Thienopyrimidone compound
11/09/2006WO2006118299A1 Gpcr inhibitor
11/09/2006WO2006117991A1 Promoter for introducing extracellular substance into mammalian ovum and introduction method
11/09/2006WO2006117608A1 Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist
11/09/2006WO2006117573A1 Combination therapy